Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Ivan D. Montoya"'
Autor:
Ivan D. Montoya, Nora D. Volkow
Publikováno v:
Pharmacological Research, Vol 200, Iss , Pp 107078- (2024)
Substance use disorders (SUDs) and drug overdose are a public health emergency and safe and effective treatments are urgently needed. Developing new medications to treat them is expensive, time-consuming, and the probability of a compound progressing
Externí odkaz:
https://doaj.org/article/744c1aaa22bd47f78f172f786c4eafff
Autor:
Iván D. Montoya, Colleen Watson, Arnie Aldridge, Danielle Ryan, Sean M. Murphy, Brenda Amuchi, Kathryn E. McCollister, Bruce R. Schackman, Joshua L. Bush, Drew Speer, Kristin Harlow, Stephen Orme, Gary A. Zarkin, Mathieu Castry, Eric E. Seiber, Joshua A. Barocas, Benjamin P. Linas, Laura E. Starbird
Publikováno v:
Addiction Science & Clinical Practice, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background Communities That HEAL (CTH) is a novel, data-driven community-engaged intervention designed to reduce opioid overdose deaths by increasing community engagement, adoption of an integrated set of evidence-based practices, and delive
Externí odkaz:
https://doaj.org/article/7852fb52ff6b4fc6903be8d37964d5c5
Autor:
Ivan D. Montoya
Publikováno v:
Mètode Revista de difusió de la investigació.
Els trastorns per us de substancies o TUS representen un problema considerable de salut publica. Per desgracia, hi ha pocs medicaments segurs i efectius per a tractar-los, i l’eficacia dels que hi ha es millorable. Hi ha importants obstacles financ
Autor:
Tatiana Ramey, Mallory J E Loflin, Joshua A. Lile, Frances R. Levin, Roger D. Weiss, Ryan Vandrey, Robert H. Dworkin, Barbara J. Mason, Brian D. Kiluk, Kathleen M. Carroll, Deborah S. Hasin, Bernard Le Foll, Erica N. Peters, Ivan D. Montoya, Alan J. Budney, Marilyn A. Huestis, Aimee L. McRae-Clark, Kevin M. Gray, Dennis C. Turk, Dustin C. Lee, Deepak Cyril D'Souza, Eric C. Strain, Will M. Aklin
Publikováno v:
Drug Alcohol Depend
There is considerable variability in the use of outcome measures in clinical trials for cannabis use disorder (CUD), and a lack of consensus regarding optimal outcomes may have hindered development and approval of new pharmacotherapies. The goal of t
Autor:
Ivan D. Montoya, Susan R.B. Weiss
Publikováno v:
Cannabis Use Disorders ISBN: 9783319903644
Cannabis is a natural product that, when used chronically, has been associated with the development of cannabis use disorder. This disorder, as described in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) of the Ameri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f2f66f181cf4b98d700eb25833b56e1
https://doi.org/10.1007/978-3-319-90365-1_1
https://doi.org/10.1007/978-3-319-90365-1_1
Autor:
Rachel L. Denlinger, Stephen S. Hecht, F. Joseph McClernon, Eric C. Donny, Andrew A. Strasser, Joni Jensen, Ryan Vandrey, Dorothy K. Hatsukami, Joseph S. Koopmeiners, Sarah S. Dermody, Paul M. Cinciripini, Neal L. Benowitz, Steven G. Carmella, Sharon E. Murphy, Chap T. Le, Ivan D. Montoya, Hilary A. Tindle, Tonya Lane, Jason D. Robinson, Mustafa al'Absi, Jennifer W. Tidey, David J. Drobes, Maxine L. Stitzer
Publikováno v:
Donny, EC; Denlinger, RL; Tidey, JW; Koopmeiners, JS; Benowitz, NL; Vandrey, RG; et al.(2015). Randomized trial of reduced-nicotine standards for cigarettes. New England Journal of Medicine, 373(14), 1340-1349. doi: 10.1056/NEJMsa1502403. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4sx5k8sd
BACKGROUND The Food and Drug Administration can set standards that reduce the nicotine content of cigarettes. METHODS We conducted a double-blind, parallel, randomized clinical trial between June 2013 and July 2014 at 10 sites. Eligibility criteria i
Autor:
Tanya Ramey, Robert H. Dworkin, Andrew S. Huhn, Robert Walsh, Ivan D. Montoya, Dennis C. Turk, Kenzie L. Preston, Kyle M. Kampman, Bethea A. Kleykamp, Roger D. Weiss, Eric C. Strain, Shannon M. Smith, Marta De Santis
Publikováno v:
Drug and Alcohol Dependence. 205:107639
Introduction The subjective experience of drug craving is a prominent and common clinical phenomenon for many individuals diagnosed with opioid use disorder (OUD), and could be a valuable clinical endpoint in medication development studies. The purpo
Autor:
Ivan D. Montoya, Susan R. B. Weiss
This book is an unbiased scientific compendium documenting the state-of-the-art in the etiology, diagnosis and treatment of Cannabis Use Disorders (CUD). Unlike any other current medical text, this volume focuses on the scientific aspects of CUDs and
Autor:
James J. Hudziak, Christian J. Hopfer, Celia B. Fisher, Margaret M. Murray, John H. Evans, Duncan B. Clark, Deborah A. Yurgelun-Todd, Susan Y. Bookheimer, Adolf Pfefferbaum, Ivan D. Montoya, Saundra A. Brown
Publikováno v:
Developmental Cognitive Neuroscience, Vol 32, Iss, Pp 143-154 (2018)
Observational neuroimaging studies with children and adolescents may identify neurological anomalies and other clinically relevant findings. Planning for the management of this information involves ethical considerations that may influence informed c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01dc6db32ef92fb283e89582a4542d27
https://europepmc.org/articles/PMC5745294/
https://europepmc.org/articles/PMC5745294/
Autor:
Ernest A. Kopecky, Raymond A. Dionne, Ivan D. Montoya, Beatrice Setnik, J. David Haddox, Bridget Martell, Jerome H. Jaffe, Dennis C. Turk, Shannon M. Smith, Ajay D. Wasan, Marsha Stanton, Judith K. Jones, Richard C. Dart, Robert H. Dworkin, Laurie B. Burke, Carl L. Roland, Jeremiah J. Trudeau, Stephen Wright, Nathaniel P. Katz, Sandra D. Comer
Accurate assessment of inappropriate medication use events (ie, misuse, abuse, and related events) occurring in clinical trials is an important component in evaluating a medication's abuse potential. A meeting was convened to review all instruments m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63fbab19bad25eb1a43ea00f6b57252d
https://europepmc.org/articles/PMC5660635/
https://europepmc.org/articles/PMC5660635/